| Gulf Coast Social Services, Inc. | |
|
5850 Florida Blvd Baton Rouge LA 70806-4247 | |
| (225) 201-0696 | |
| (225) 201-1792 |
| Full Name | Gulf Coast Social Services, Inc. |
|---|---|
| Speciality | Community/behavioral Health |
| Location | 5850 Florida Blvd, Baton Rouge, Louisiana |
| Authorized Official Name and Position | Willie Green (CEO) |
| Authorized Official Contact | 5048316561 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Gulf Coast Social Services, Inc. 2400 Edenborn Ave Metairie LA 70001-1817 Ph: (504) 831-6561 | Gulf Coast Social Services, Inc. 5850 Florida Blvd Baton Rouge LA 70806-4247 Ph: (225) 201-0696 |
| NPI Number | 1033441985 |
|---|---|
| Provider Enumeration Date | 02/03/2010 |
| Last Update Date | 09/27/2022 |
| Certification Date | 09/27/2022 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033441985 | NPI | - | NPPES |
| 1534854 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 251S00000X | Community/behavioral Health | ADC6594 (Louisiana) | Primary |
News Archive
Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the research and development of mRNA and microRNA targeted therapies, today announced that the Company has obtained an exclusive license from Massachusetts General Hospital for intellectual property related to the regulation of miR-33 for the treatment of cardiovascular disorders.
Shire plc, the global specialty biopharmaceutical company, today announced that the European Medicines Agency has approved the purification of REPLAGAL® (agalsidase alfa) drug substance at its new manufacturing facility in Lexington, MA, US. REPLAGAL, Shire's enzyme replacement therapy for the treatment of Fabry disease is the first product that will be made available to patients from the new facility.
A series of studies published in the September Journal of Nuclear Medicine (JNM) show that molecular imaging plays a critical role in the evaluation and treatment planning for a broad spectrum of cancers, including thyroid cancer and lymphoma.
With over 1,400 products in active development, the innovation pipeline for cardiovascular disease (CVD) is extensive, with four key CVD indications – hypertension, heart failure, dyslipidemia and thrombosis – now accounting for around half of all pipeline innovation, according to GBI Research, a recognized leader in providing business information and analytics.
› Verified 3 days ago
Plauche Mental Health Corporation Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1983 Peck Dr, Baton Rouge, LA 70810 Phone: 225-761-8816 | |
Sanabit Behavioral Health, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 673 E Airport Ave, Baton Rouge, LA 70806 Phone: 225-300-8788 Fax: 225-308-8301 | |
Strong Family Project Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 990 Ponderosa Dr, Baton Rouge, LA 70819 Phone: 225-803-9054 | |
Small Talk Counseling & Consulting Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4521 Jamestown Ave Ste 6, Baton Rouge, LA 70808 Phone: 225-341-2853 | |
Elevation Wellness Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 12613 Bristol Ave, Baton Rouge, LA 70815 Phone: 225-803-9462 | |
Hearthstone Clinic Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 13005 Justice Ave, Baton Rouge, LA 70816 Phone: 318-355-7066 | |
Serenity Center Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1023 N Lobdell Ave, Baton Rouge, LA 70806 Phone: 225-925-0555 Fax: 225-925-0082 |